Clinical Trials Directory

Trials / Completed

CompletedNCT02085980

Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
El. En. SpA · Industry
Sex
Female
Age
45 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the safety and the efficacy of a laser in the treatment of vulvovaginal atrophy (VVA), that is to assess the change in the severity of the vaginal dryness symptom, by means of a visual analogic scale (10 cm VAS).

Detailed description

The laser handpiece (probe) will be deposited in the vaginal canal and the laser energy will be delivered through the handpiece. Subjects will receive a total of three (3) treatments every six (6) weeks (+/-1 week). Subjects will return one week (+/- 3 days) post the first treatment, as well as three (3) months (+/- 2 weeks) and twelve (12) months (+/- 2 weeks) post the third treatment.

Conditions

Interventions

TypeNameDescription
DEVICELaser treatmentThe laser handpiece (probe) will be deposited in the vaginal canal and the laser energy will be delivered through the handpiece

Timeline

Start date
2014-03-01
Primary completion
2015-08-01
Completion
2015-11-01
First posted
2014-03-13
Last updated
2021-06-04
Results posted
2021-06-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02085980. Inclusion in this directory is not an endorsement.

Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy (NCT02085980) · Clinical Trials Directory